News | September 27, 2024
Alembic receives USFDA final approval for Paliperidone ER tablets
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
The Notes shall not be offered or sold in India
Pfizer's decision is based on the totality of clinical data
Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Doses will be ready to ship to applicable European Union (EU) member states as soon as possible upon European Commission (EC) authorization
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Stable profits, low leverage to keep credit profiles comfortable
Subscribe To Our Newsletter & Stay Updated
